HIIT obesity study moves to not yet recruiting as obesity trials keep building — LiveFuture News
Open on LiveFuture.ai →

HIIT obesity study moves to not yet recruiting as obesity trials keep building

A new ClinicalTrials.gov registry observation adds a randomized HIIT study in human clinical obesity, with body fat mass tracked over 8 weeks and results still pending.

A new obesity study on High-Intensity Interval Training has been listed as NOT_YET_RECRUITING, and that matters because it points to another controlled test of exercise in human clinical obesity rather than a finished result. The registry observation was published 2026-11-18T00:00:00+00:00, and no study outcomes have been posted yet.

The trial is randomized and compares High-Intensity Interval Training (HIIT) with a Control group. Its main readout is total body fat mass, measured by bioelectrical impedance analysis, with change from baseline to Week 8 as the primary outcome.

"This record describes a study and its registry status; study outcomes require posted results." Source: ctgov_v2

What the study is set up to test

The study title links HIIT with inflammatory biomarkers and circulating microRNAs in human clinical obesity, but the registry details shown here focus on the trial structure and the fat-mass outcome. That means the public can see what the team plans to measure without assuming any answer in advance.

The sponsor is Universidad Nacional Andres Bello, and the study title is paired with a no-intervention control arm. In plain terms, the trial is designed to compare a structured exercise approach with doing nothing new, then check whether body fat mass changes over the short intervention window.

"The study title is 'High-Intensity Interval Training, Inflammatory Biomarkers, and Circulating MicroRNAs in Human Clinical Obesity.'" Source: ctgov_v2

Why it fits the wider obesity research picture

This registry entry also sits inside the active Obesity & Metabolic special event, where several other obesity-related trials are listed with different approaches, from exercise to medicines to questions about metabolism and behavior. The shared topic is broad, but the common thread is clear: researchers are still testing multiple ways to address obesity and related health risks.

Within that wider set, the HIIT study adds an exercise-focused path alongside trials that are recruiting, not yet recruiting, or active not recruiting. For readers, the practical takeaway is simple: obesity research is moving on several fronts at once, and this study adds another exercise-led comparison to that mix.